SCHEMBL3549232

SCHEMBL3549232

CCC(=O)c1cc(F)c(Br)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.50
ALDH1A1 P00352 6/20 0.49
HPGD P15428 4/20 0.49
TSHR P16473 2/20 0.49
GAA P10253 1/20 0.42
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
POLB P06746 2/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RAB9A P51151 3/20 0.37
ATM Q13315 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
NPC1 O15118 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3547368 0.83 CES2 (0.56) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL24526991 0.81 HDAC1 (0.46) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL18356296 0.81 PTPN1 (0.52) HDAC1HDAC6CES2CES1
SCHEMBL3085193 0.81 MAPT (0.47) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL13971730 0.81 HDAC1 (0.53) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL8159099 0.79 MAPT (0.46) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL18355570 0.79 GSK3B (0.43) MAPTALDH1A1POLBHDAC1HDAC6
SCHEMBL1349781 0.79 MAPT (0.54) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL6013773 0.78 MAPT (0.43) MAPTALDH1A1HPGDTSHRGAA
SCHEMBL24451058 0.78 MAPT (0.45) MAPTALDH1A1HPGDTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US disclosed
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US disclosed
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US disclosed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US disclosed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US disclosed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US disclosed
EP-1935881-A1 ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-25 EP disclosed
EP-1935881-A1 ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds OPRL1, NPSR1, NPBWR1 MAPT 2946/4885ALDH1A1 1623/4885HPGD 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.